Efficacy of a novel antibody-drug conjugate (ADC), ABT-414, as monotherapy in epidermal growth factor receptor (EGFR) amplified, recurrent glioblastoma (GBM) Conference Paper uri icon

authors

  • van den Bent, M
  • Gan, Hui
  • Lassman, AB
  • Kumthekar, P
  • Butowski, N
  • Lwin, Z
  • Nabors, LB
  • Simes, J
  • Holen, K
  • Reardon, DA

publication date

  • 2016